Tcn Prime Overview
- Year Founded
-
2023
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
7
Tcn Prime General Information
Description
Manufacturer of medical devices intended for the cardiovascular medicine field. The company offers medical devices that are distinct from extracorporeal circulation with artificial lung and pump catheters, with a balloon catheter for the treatment of aortic valve stenosis, enabling the healthcare industry to save the lives of patients by placing minimal strain on the patient's body
Contact Information
Website
www.tcn-prime.jpCorporate Office
- Nci Incubator, 1-28-10 Hongo
- Bunkyo-ku
- Tokyo, 113-0033
- Japan
Corporate Office
- Nci Incubator, 1-28-10 Hongo
- Bunkyo-ku
- Tokyo, 113-0033
- Japan
Tcn Prime Timeline
Tcn Prime Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 04-Mar-2026 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 25-Aug-2025 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 15-Jul-2025 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 06-Jan-2025 | $824K | Completed | Generating Revenue | ||
| 1. Seed Round | 28-Jun-2024 | $824K | $824K | Completed | Generating Revenue |
Tcn Prime Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class A shares |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Tcn Prime Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Tcn Prime Patents
Tcn Prime Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-7887148-B1 | Double-membrane balloon catheter | Active | 16-Oct-2025 | ||
| JP-7799298-B1 | Antegrade blood infusion cannula | Active | 10-Jul-2024 | ||
| WO-2026014063-A1 | Antegrade blood supply cannula | Pending | 10-Jul-2024 | ||
| JP-2025179711-A | Catheter | Pending | 28-May-2024 |
Tcn Prime Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Kansai Startup Incubation | Accelerator/Incubator | |||
| Neuroceuticals | Venture Capital | Minority | ||
| RMD Partners | Venture Capital | Minority | ||
| 0>1 Start | Accelerator/Incubator | |||
| Tx Entrepreneur Partners | Angel Group |
Tcn Prime FAQs
-
When was Tcn Prime founded?
Tcn Prime was founded in 2023.
-
Where is Tcn Prime headquartered?
Tcn Prime is headquartered in Tokyo, Japan.
-
What industry is Tcn Prime in?
Tcn Prime’s primary industry is Medical Supplies.
-
Is Tcn Prime a private or public company?
Tcn Prime is a Private company.
-
What is Tcn Prime’s current revenue?
The current revenue for Tcn Prime is .
-
How much funding has Tcn Prime raised over time?
Tcn Prime has raised $2.45M.
-
Who are Tcn Prime’s investors?
Kansai Startup Incubation, Neuroceuticals, RMD Partners, 0>1 Start, and Tx Entrepreneur Partners are 5 of 7 investors who have invested in Tcn Prime.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
